Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study. (September 2016)
- Record Type:
- Journal Article
- Title:
- Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study. (September 2016)
- Main Title:
- Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study
- Authors:
- Twu, Nae-Fang
Ou, Yu-Che
Liao, Cheng-I.
Chang, Wei-Yang
Yang, Lan-Yan
Tang, Yun-Hsin
Chen, Tze-Chien
Chen, Chi-Hau
Chen, Tze-Ho
Yeh, Lain-Shung
Hsu, Shih-Tien
Chen, Yu-Chieh
Chang, Cheng-Chang
Cheng, Ya-Min
Huang, Chia-Yen
Liu, Fu-Shing
Lin, Yue-Shan
Hsiao, Sheng-Mou
Kan, Yuan-Yee
Lai, Chyong-Huey - Abstract:
- Abstract: Objective: We aimed to identify prognostic factors of early-stage cervical adenocarcinoma (AC) and adenosquamous carcinoma (ASC) treated with primary radical surgery, and to evaluate the impact of postoperative adjuvant therapy on outcome. Methods: The clinical-pathological data of all patients (n = 1132) with stages I-II cervical AC/ASC treated with primary radical surgery at the member hospitals of the Taiwanese Gynecologic Oncology Group were retrospectively reviewed. Results: In multivariate analysis, stage II, deep stromal invasion (DSI), lymphovascular space invasion (LVSI), positive pelvic lymph node (PLN), and parametrial involvement (PI) were significant factors for recurrence-free survival (RFS), while only DSI, PI, and positive PLN were independent factors for cancer-specific survival (CSS). Low- and high-risk groups were defined by prognostic scores derived from the four factors (DSI, LVSI, positive PLN, PI) selected by internal validation. Postoperative adjuvant therapy significantly improved outcome for PLN-positive patients (RFS, p = 0.014; CSS, p = 0.016), but not for PLN-negative high-risk group because of higher mean prognostic score ( p = 0.028) of adjuvant+ than adjuvant− patients. Conclusions: PLN metastasis, PI, DSI, and LVSI were independent prognostic factors. Prospective studies of postoperative adjuvant therapy with prognostic score and nodal status stratification for cervical AC/ASC are necessary. Highlights: Stage, pelvic nodeAbstract: Objective: We aimed to identify prognostic factors of early-stage cervical adenocarcinoma (AC) and adenosquamous carcinoma (ASC) treated with primary radical surgery, and to evaluate the impact of postoperative adjuvant therapy on outcome. Methods: The clinical-pathological data of all patients (n = 1132) with stages I-II cervical AC/ASC treated with primary radical surgery at the member hospitals of the Taiwanese Gynecologic Oncology Group were retrospectively reviewed. Results: In multivariate analysis, stage II, deep stromal invasion (DSI), lymphovascular space invasion (LVSI), positive pelvic lymph node (PLN), and parametrial involvement (PI) were significant factors for recurrence-free survival (RFS), while only DSI, PI, and positive PLN were independent factors for cancer-specific survival (CSS). Low- and high-risk groups were defined by prognostic scores derived from the four factors (DSI, LVSI, positive PLN, PI) selected by internal validation. Postoperative adjuvant therapy significantly improved outcome for PLN-positive patients (RFS, p = 0.014; CSS, p = 0.016), but not for PLN-negative high-risk group because of higher mean prognostic score ( p = 0.028) of adjuvant+ than adjuvant− patients. Conclusions: PLN metastasis, PI, DSI, and LVSI were independent prognostic factors. Prospective studies of postoperative adjuvant therapy with prognostic score and nodal status stratification for cervical AC/ASC are necessary. Highlights: Stage, pelvic node metastasis, parametrial involvement, DSI, and LVSI were independent prognostic factors for cervical adeno-adenosquamous carcinoma. Adjuvant therapy after radical surgery significantly improved survival for node-positive but not for node-negative high-risk group. Prospective studies with prognostic score and nodal status stratification for high-risk cervical adeno-adenosquamous carcinoma are necessary. … (more)
- Is Part Of:
- Surgical oncology. Volume 25:Number 3(2016)
- Journal:
- Surgical oncology
- Issue:
- Volume 25:Number 3(2016)
- Issue Display:
- Volume 25, Issue 3 (2016)
- Year:
- 2016
- Volume:
- 25
- Issue:
- 3
- Issue Sort Value:
- 2016-0025-0003-0000
- Page Start:
- 229
- Page End:
- 235
- Publication Date:
- 2016-09
- Subjects:
- Cervical cancer -- Adenocarcinoma -- Adenosquamous carcinoma -- Prognostic factor -- Adjuvant therapy
Cancer -- Surgery -- Periodicals
Neoplasms -- surgery -- Periodicals
Cancer -- Chirurgie -- Périodiques
Electronic journals
616.994059 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09607404 ↗
http://www.so-online.net/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09607404 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09607404 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.suronc.2016.05.028 ↗
- Languages:
- English
- ISSNs:
- 0960-7404
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8548.242000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 1382.xml